王永福 , 刘媛 . 自身抗体在肿瘤及感染性疾病发生、发展中的作用[J]. 北京大学学报（医学版）, 2018 , 50(6) : 952 -955 . DOI: 10.19723/j.issn.1671-167X.2018.06.002
| [1] | Burnham TK . Antinuclear antibodies in patients with malignancies[J]. Lancet, 1972,2(7774):436. |
| [2] | Vlagea A, Falagan S, Gutierrez-Gutierrez G , et al. Antinuclear antibodies and cancer: A literature review[J]. Crit Rev Oncol Hematol, 2018,127:42-49. |
| [3] | Sahin U, Tureci O, Schmitt H , et al. Human neoplasms elicit multiple specific immune responses in the autologous host[J]. Proc Natl Acad Sci USA, 1995,92(25):11810-11813. |
| [4] | Dellen H, Seemayer NH . Autoimmunity in patients with bronchogenic carcinomas: occurrence of antibodies against nuclear antigens, chromosomes and ds-deoxyribonucleic acid[J]. Zentralbl Bakteriol Mikrobiol Hyg B, 1983,177(6):451-468. |
| [5] | Riska H, Fyhrquist F, Selander RK , et al. Systemic lupus erythematosus and DNA antibodies in pleural effusions[J]. Scand J Rheumatol, 1978,7(3):159-160. |
| [6] | Attar SM, Koshak EA . Medical conditions associated with a positive anti-double-stranded deoxyribonucleic acid[J]. Saudi Med J, 2010,31(7):781-787. |
| [7] | Cavagna L, Prisco E, Montecucco C , et al. Association between anti-dsDNA titre increase and thymoma relapse[J]. Clin Exp Rheumatol, 2011,29(3):599-600. |
| [8] | 邹和建 . 系统性红斑狼疮与自身抗体[J]. 皮肤科学通报, 2018,35(3):258-264. |
| [9] | Katz U, Zandman-Goddard G . Drug-induced lupus: an update[J]. Autoimmun Rev, 2010,10(1):46-50. |
| [10] | Kamei M, Kato M, Mochizuki K , et al. Serodiagnosis of cancers by ELISA of anti-histone H2B antibody[J]. Biotherapy, 1992,4(1):17-22. |
| [11] | Sakamoto J, Fujiya M, Okamoto K , et al. Immunoprecipitation of nucleosomal DNA is a novel procedure to improve the sensitivity of serum screening for the p16 hypermethylation associated with colon cancer[J]. Cancer Epidemiol, 2010,34(2):194-199. |
| [12] | Fragkioudaki S, Mavragani CP, Moutsopoulos HM . Predicting the risk for lymphoma development in Sj?gren syndrome: An easy tool for clinical use[J]. Medicine, 2016,95(25):e3766. |
| [13] | Quartuccio L, Baldini C, Bartoloni E , et al. Anti-SSA/SSB-negative Sj?gren’s syndrome shows a lower prevalence of lymphoproliferative manifestations, and a lower risk of lymphoma evolution[J]. Autoimmun Rev, 2015,14(11):1019-1022. |
| [14] | Matsuda M , Yamada T. snRNPs from mouse teratocarcinoma cells reacting with polyclonal anti-Sm and anti-m3(2,2,7)G antibodies and bioche-mical characterization of the snRNPs[J]. Nihon Juigaku Zasshi, 1987,49(6):981-987. |
| [15] | Imran A, Neelam F, Tariq M . Incidence of circulating antinuclear antibodies in cancer patients[J]. Indian J Med Sci, 2003,57(3):113-116. |
| [16] | Zou HY, Gu X, Yu WZ , et al. Detection of serum antinuclear antibodies in lymphoma patients[J]. Genet Mol Res, 2015,14(4):16546-16552. |
| [17] | Fernandez-Madrid F , VandeVord PJ, Yang X, et al. Antinuclear antibodies as potential markers of lung cancer[J]. Clin Cancer Res, 1999,5(6):1393-1400. |
| [18] | Syrigos KN, Charalambopoulos A, Pliarchopoulou K , et al. The prognostic significance of autoantibodies against dsDNA in patients with colorectal adenocarcinoma[J]. Anticancer Res, 2000,20(6B):4351-4353. |
| [19] | Mitchell P, Thatcher N, Socinski MA , et al. Tecemotide in unresectable stage III non-small-cell lung cancer in the phase III START study: updated overall survival and biomarker analyses[J]. Ann Oncol, 2015,26(6):1134-1142. |
| [20] | Maire C, Vercambre-Darras S, Devos P , et al. Metastatic melanoma: spontaneous occurrence of auto antibodies is a good prognosis factor in a prospective cohort[J]. J Eur Acad Dermatol Venereol, 2013,27(1):92-96. |
| [21] | Altintas A, Cil T, Pasa S , et al. Clinical significance of elevated antinuclear antibody test in patients with Hodgkin’s and non-Hodgkin’s lymphoma: a single center experience[J]. Minerva Med, 2008,99(1):7-14. |
| [22] | Tan EM . Antinuclear antibodies: diagnostic markers for autoimmune diseases and probes for cell biology[J]. Adv Immunol, 1989,44:93-151. |
| [23] | Ringrose JH, Muijsers AO, Pannekoek Y , et al. Influence of infection of cells with bacteria associated with reactive arthritis on the peptide repertoire presented by HLA-B27[J]. J Med Microbiol, 2001,50(4):385-389. |
| [24] | Clark SE, Weiser JN . Microbial modulation of host immunity with the small molecule phosphorylcholine[J]. Infect Immun, 2013,81(2):392-401. |
| [25] | Flodstrom-Tullberg M . Viral infections: their elusive role in regulating susceptibility to autoimmune disease[J]. Microbes Infect, 2003,5(10):911-921. |
| [26] | Monsalve DM, Pacheco Y, Acosta-Ampudia Y , et al. Zika virus and autoimmunity. One-step forward[J]. Autoimmun Rev, 2017,16(12):1237-1245. |
| [27] | Sene D, Piette JC, Cacoub P . Antiphospholipid antibodies, antiphospholipid syndrome and infections[J]. Autoimmun Rev, 2008,7(4):272-277. |
| [28] | Tanay A . Chikungunya virus and autoimmunity[J]. Curr Opin Rheumatol, 2017,29(4):389-393. |
| [29] | Wan SW, Lin CF, Yeh TM , et al. Autoimmunity in dengue pathogenesis[J]. J Formos Med Assoc, 2013,112(1):3-11. |
| [30] | Garzelli C, Pacciardi A, Basolo F , et al. Mechanisms other than polyclonal B cell activation possibly involved in Epstein-Barr virus-induced autoimmunity[J]. Clin Exp Immunol, 1989,76(3):412-416. |
| [31] | Kivity S, Agmon-Levin N, Blank M , et al. Infections and autoimmunity: friends or foes?[J]. Trends Immunol, 2009,30(8):409-414. |
| [32] | Rubtsova K , Rubtsov AV, van Dyk LF, et al. T-box transcription factor T-bet, a key player in a unique type of B-cell activation essential for effective viral clearance[J]. Proc Natl Acad Sci USA, 2013,110(34):E3216-3224. |
| [33] | Yee LJ, Kelleher P, Goldin RD , et al. Antinuclear antibodies (ANA) in chronic hepatitis C virus infection: correlates of positivity and clinical relevance[J]. J Viral Hepat, 2004,11(5):459-464. |
| [34] | Hao Y , O’Neill P, Naradikian MS, et al. A B-cell subset uniquely responsive to innate stimuli accumulates in aged mice[J]. Blood, 2011,118(5):1294-1304. |
| [35] | Litwin CM, Binder SR . ANA testing in the presence of acute and chronic infections[J]. J Immunoassay Immunochem, 2016,37(5):439-452. |
| [36] | Shoenfeld Y, Vilner Y, Coates AR , et al. Monoclonal anti-tuberculosis antibodies react with DNA, and monoclonal anti-DNA autoantibodies react with Mycobacterium tuberculosis[J]. Clin Exp Immunol, 1986,66(2):255-261. |
| [37] | Faaber P, Capel PJ, Rijke GP , et al. Cross-reactivity of anti-DNA antibodies with proteoglycans[J]. Clin Exp Immunol, 1984,55(3):502-508. |
/
| 〈 |
|
〉 |
